Yali Wei

Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells

Hong-Yang Wang, D. Cao, Lei Chen, 2022, Acta Pharmacologica Sinica.